Literature DB >> 3090926

Qualitative differences in effects of recombinant alpha-, beta- and gamma-interferons on human peripheral blood leukocytes in vitro.

C Billard, D Ferbus, J P Kolb, F Rosa, J Y Perrot, G Merlin, P Janiaud, N Raynaud, M N Thang, M Fellous.   

Abstract

The in vitro effects of bacteria-produced human interferons alpha 2, beta and gamma on several properties of peripheral blood leukocytes from different healthy donors were compared. Treatment with HuIFN-alpha 2 or HuIFN-beta resulted in inhibition of the proliferative response to phytohaemagglutinin and in closely parallel induction of 2'-5'-oligoadenylate synthetase activity. In contrast, HuIFN-gamma had no significant effect on these two activities. However, all three HuIFN were able to enhance natural killer cell cytotoxicity and the expression of HLA-DR surface antigens, with only quantitative variations from donor to donor. Similar results were observed with glycosylated recombinant hamster-cell-derived HuIFN-gamma and with natural HuIFN-gamma. These data demonstrate qualitative differences in the effects of HuIFN-gamma compared to those of HuIFN-alpha 2 or -beta on cells of the immune system.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3090926     DOI: 10.1016/s0771-050x(86)80045-6

Source DB:  PubMed          Journal:  Ann Inst Pasteur Immunol (1985)


  4 in total

Review 1.  Interferon for treatment: the dust settles.

Authors:  D Galvani; S D Griffiths; J C Cawley
Journal:  Br Med J (Clin Res Ed)       Date:  1988-06-04

2.  Interferon-gamma (IFN-gamma) and interleukin-2 in the generation of lymphokine-activated killer cell cytotoxicity--IFN-gamma-induced suppressive activity.

Authors:  M Toledano; C Mathiot; J Michon; G Andreu; D Lando; M Brandely; W H Fridman
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

3.  Coexpression of intercellular adhesion molecule-1 and class I major histocompatibility complex antigens on hepatocyte membrane in chronic viral hepatitis.

Authors:  C M Chu; Y F Liaw
Journal:  J Clin Pathol       Date:  1993-11       Impact factor: 3.411

4.  2',5'-Oligoadenylate synthetase levels in patients with multiple myeloma receiving maintenance therapy with interferon alpha 2b do not correlate with clinical response.

Authors:  B C Millar; J B Bell
Journal:  Br J Cancer       Date:  1995-12       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.